Loading…

Safety and immunogenicity of H5N1 vaccine

We believe that trials assessing new vaccines containing aluminium hydroxide adjuvant should include long-term follow-up of enrolled participants.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2006-12, Vol.368 (9554), p.2209-2210
Main Authors: Authier, FJ, Gherardi, RK
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We believe that trials assessing new vaccines containing aluminium hydroxide adjuvant should include long-term follow-up of enrolled participants.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(06)69891-7